Comparison between Dindigul Farm Product IPO and Medicamen Organics IPO.
Dindigul Farm Product IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Medicamen Organics IPO is a SME Bookbuilding proposed to list at NSE SME.
| Dindigul Farm Product IPO | Medicamen Organics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dindigul Farm Product IPO is up to ₹33.07 Cr whereas the issue size of the Medicamen Organics IPO is up to ₹9.96 Cr. The final issue price of Dindigul Farm Product IPO is ₹54.00 per share and of Medicamen Organics IPO is ₹34.00 per share.
| Dindigul Farm Product IPO | Medicamen Organics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹51.00 per share | ₹32.00 per share |
| Issue Price (Upper) | ₹54.00 per share | ₹34.00 per share |
| Issue Price (Final) | ₹54.00 per share | ₹34.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 61,24,000 shares | 29,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹33.07 Cr | up to ₹9.96 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 61,24,000 shares | 29,28,000 shares |
| Issue Size Total (Amount) | up to ₹33.07 Cr | up to ₹9.96 Cr |
Dindigul Farm Product IPO opens on Jun 20, 2024, while Medicamen Organics IPO opens on Jun 21, 2024. The closing date of Dindigul Farm Product IPO and Medicamen Organics IPO is Jun 24, 2024, and Jun 25, 2024, respectively.
| Dindigul Farm Product IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Bid Date | Jun 19, 2024 | Jun 20, 2024 |
| Issue Open | Jun 20, 2024 | Jun 21, 2024 |
| Issue Close | Jun 24, 2024 | Jun 25, 2024 |
| Basis Of Allotment (Tentative) | Jun 25, 2024 | Jun 26, 2024 |
| Initiation of Refunds (Tentative) | Jun 26, 2024 | Jun 27, 2024 |
| Credit of Share (Tentative) | Jun 26, 2024 | Jun 27, 2024 |
| Listing date (Tentative) | Jun 27, 2024 | Jun 28, 2024 |
| Anchor Lockin End date 1 | Jul 25, 2024 | Jul 26, 2024 |
| Anchor Lockin End date 2 | Sep 23, 2024 | Sep 24, 2024 |
Dindigul Farm Product IPO P/E ratio is 18.47, as compared to Medicamen Organics IPO P/E ratio of 30.53.
| Dindigul Farm Product IPO | Medicamen Organics IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 80.66 | 81.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 18.47 | 30.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹131.92 Cr. | ₹39.78 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -95 | 19.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 62 | 14.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 4.63 | 0.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.92 | ₹1.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 149.36 | 15.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dindigul Farm Product IPO Retail Individual Investors (RII) are offered 21,44,000 shares while in Medicamen Organics IPO retail investors are offered 21,44,000 shares. Qualified Institutional Buyers (QIB) are offered 12,26,000 shares in Dindigul Farm Product IPO and 5,84,000 shares in Medicamen Organics IPO.
| Dindigul Farm Product IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,34,000 shares | 8,76,000 shares |
| Market Maker Reservation | 3,26,000 shares | 1,72,000 shares |
| QIB | 12,26,000 shares | 5,84,000 shares |
| NII | 9,20,000 shares | 4,40,000 shares |
| RII | 21,44,000 shares | 10,28,000 shares |
| Employee | ||
| Others | ||
| Total | 61,24,000 shares | 29,28,000 shares |
Dindigul Farm Product IPO subscribed 202.35x in total, whereas Medicamen Organics IPO subscribed 993.56x.
| Dindigul Farm Product IPO | Medicamen Organics IPO | |
|---|---|---|
| QIB (times) | 145.62x | 173.03x |
| NII (times) | 280.06x | 1,343.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 201.44x | 1,309.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 202.35x | 993.56x |
